Publicaciones en las que colabora con PATRICIA LOPEZ SUAREZ (43)

2023

  1. Humoral responses against HDL are linked to lipoprotein traits, atherosclerosis, inflammation and pathogenic pathways during early arthritis stages

    Rheumatology (Oxford, England), Vol. 62, Núm. 8, pp. 2898-2907

2021

  1. Profiling of Serum Oxylipins During the Earliest Stages of Rheumatoid Arthritis

    Arthritis and Rheumatology, Vol. 73, Núm. 3, pp. 401-413

2020

  1. Erratum: Low-density granulocytes and monocytes as biomarkers of cardiovascular risk in systemic lupus erythematosus (Rheumatology (2020) 59 (1752-1764) DOI: 10.1093/rheumatology/keaa016)

    Rheumatology (United Kingdom)

  2. Glyca levels during the earliest stages of rheumatoid arthritis: Potential use as a biomarker of subclinical cardiovascular disease

    Journal of Clinical Medicine, Vol. 9, Núm. 8, pp. 1-19

  3. IgM anti-phosphorylcholine antibodies associate with senescent and IL-17+ T cells in SLE patients with a pro-inflammatory lipid profile

    Rheumatology (Oxford, England), Vol. 59, Núm. 2, pp. 407-417

  4. Low-density granulocytes and monocytes as biomarkers of cardiovascular risk in systemic lupus erythematosus

    Rheumatology (Oxford, England), Vol. 59, Núm. 7, pp. 1752-1764

  5. Relationship Between T-Cell Exosomes and Cellular Subsets in SLE According to Type I IFN-Signaling

    Frontiers in Medicine, Vol. 7

2019

  1. Clinical and subclinical cardiovascular disease in female SLE patients: Interplay between body mass index and bone mineral density

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 29, Núm. 2, pp. 135-143

  2. IRF4 and IRGS delineate clinically relevant gene expression signatures in systemic lupus erythematosus and rheumatoid arthritis

    Frontiers in Immunology, Vol. 10, Núm. JAN

  3. Vitamin D Receptor Polymorphism and DHCR7 Contribute to the Abnormal Interplay Between Vitamin D and Lipid Profile in Rheumatoid Arthritis

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Anti-high-density lipoprotein antibodies and antioxidant dysfunction in immune-driven diseases

    Frontiers in Medicine, Vol. 5, Núm. APR

  2. Anti-high-density lipoprotein antibodies and antioxidant dysfunction in immune-driven diseases

    Frontiers in Medicine, Vol. 5, Núm. APR

  3. Endothelial progenitor cells as mediators of the crosstalk between vascular repair and immunity: Lessons from systemic autoimmune diseases

    Current Medicinal Chemistry, Vol. 25, Núm. 35, pp. 4478-4496

  4. Heterogeneity of the type I interferon signature in rheumatoid arthritis: A potential limitation for its use as a clinical biomarker

    Frontiers in Immunology, Vol. 8, Núm. JAN

  5. Profiling of B-Cell Factors and Their Decoy Receptors in Rheumatoid Arthritis: Association With Clinical Features and Treatment Outcomes

    Frontiers in immunology, Vol. 9, pp. 2351

2017

  1. Circulating microparticle subpopulations in systemic lupus erythematosus are affected by disease activity

    International Journal of Cardiology, Vol. 236, pp. 138-144

  2. High triglycerides and low high-density lipoprotein cholesterol lipid profile in rheumatoid arthritis: A potential link among inflammation, oxidative status, and dysfunctional high-density lipoprotein

    Journal of Clinical Lipidology, Vol. 11, Núm. 4, pp. 1043-1054.e2

  3. Intestinal dysbiosis is associated with altered short-chain fatty acids and serum-free fatty acids in systemic lupus erythematosus

    Frontiers in Immunology, Vol. 8, Núm. JAN

  4. Serum levels of anti-PON1 and anti-HDL antibodies as potential biomarkers of premature atherosclerosis in systemic lupus erythematosus

    Thrombosis and Haemostasis, Vol. 117, Núm. 11, pp. 2194-2206

2016

  1. A pathogenic IFNα, BLyS and IL-17 axis in systemic lupus erythematosus patients

    Scientific Reports, Vol. 6